Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)

The article presents a literature review on the mechanisms of anemia in patients with hematologic malignancies and a classification of chronic anemia and methods of its correction. It describes in detail the mechanism of action, indications and side effects of rembinant erythropoietin (rEPO). It giv...

Full description

Bibliographic Details
Main Author: N. A. Romanenko
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/50
_version_ 1826557234987925504
author N. A. Romanenko
author_facet N. A. Romanenko
author_sort N. A. Romanenko
collection DOAJ
description The article presents a literature review on the mechanisms of anemia in patients with hematologic malignancies and a classification of chronic anemia and methods of its correction. It describes in detail the mechanism of action, indications and side effects of rembinant erythropoietin (rEPO). It gives anemia treatment algorithms with rEPO in patients with chronic blood malignancies. The analysis of rEPO efficacy is shown in anemia treatment in patients with various types of cancer. It presents the recommendations of ASCO/ASH for the use of rEPO in various patients categories.
first_indexed 2024-04-09T20:25:49Z
format Article
id doaj.art-c0ef1c28fe164e188d6d746de7df5900
institution Directory Open Access Journal
issn 1818-8346
2413-4023
language Russian
last_indexed 2025-03-14T08:25:22Z
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj.art-c0ef1c28fe164e188d6d746de7df59002025-03-02T13:07:08ZrusABV-pressОнкогематология1818-83462413-40232014-07-0173222910.17650/1818-8346-2012-7-3-22-2965Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)N. A. Romanenko0Russian Research Institute of Hematology and Transfusiology, Russian Federal Medico‑biological AgencyThe article presents a literature review on the mechanisms of anemia in patients with hematologic malignancies and a classification of chronic anemia and methods of its correction. It describes in detail the mechanism of action, indications and side effects of rembinant erythropoietin (rEPO). It gives anemia treatment algorithms with rEPO in patients with chronic blood malignancies. The analysis of rEPO efficacy is shown in anemia treatment in patients with various types of cancer. It presents the recommendations of ASCO/ASH for the use of rEPO in various patients categories.https://oncohematology.abvpress.ru/ongm/article/view/50anemianon hodgkin’s lymphomaslymphoproliferative disordersmultiple myelomachronic myeloid leukemiamyelodisplastic syndromehemoglobinerythropoietindarbepoetinchemotherapyred blood cell transfusion
spellingShingle N. A. Romanenko
Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
Онкогематология
anemia
non hodgkin’s lymphomas
lymphoproliferative disorders
multiple myeloma
chronic myeloid leukemia
myelodisplastic syndrome
hemoglobin
erythropoietin
darbepoetin
chemotherapy
red blood cell transfusion
title Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
title_full Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
title_fullStr Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
title_full_unstemmed Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
title_short Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
title_sort pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents review
topic anemia
non hodgkin’s lymphomas
lymphoproliferative disorders
multiple myeloma
chronic myeloid leukemia
myelodisplastic syndrome
hemoglobin
erythropoietin
darbepoetin
chemotherapy
red blood cell transfusion
url https://oncohematology.abvpress.ru/ongm/article/view/50
work_keys_str_mv AT naromanenko pathogenesisandtherapyofanemiainoncohemathologypatientswithrecombinanterythropoietinagentsreview